Search This Blog

Tuesday, June 16, 2026

Sanuwave cuts Q2 26 revenue guidance to $8.5–$9.5 m on market disruption, Ultramist cannibalization

 

Sanuwave Health cuts Q2 2026 revenue guidance to $8.5–$9.5 million on market disruption, Ultramist cannibalization

  • Revised Q2 2026 revenue outlook of $8.5–$9.5 million is below Sanuwave Health's prior expectations.
  • Company cites market disruption and used Ultramist systems cannibalizing new equipment sales as primary headwinds.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)